KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Interest Expenses (2018 - 2019)

Historic Interest Expenses for Acadia Pharmaceuticals (ACAD) over the last 4 years, with Q2 2019 value amounting to $12000.0.

  • Acadia Pharmaceuticals' Interest Expenses fell 9514.17% to $12000.0 in Q2 2019 from the same period last year, while for Mar 2020 it was $12000.0, marking a year-over-year decrease of 9942.0%. This contributed to the annual value of $1.8 million for FY2018, which is N/A changed from last year.
  • As of Q2 2019, Acadia Pharmaceuticals' Interest Expenses stood at $12000.0, which was down 9514.17% from $229000.0 recorded in Q1 2019.
  • Acadia Pharmaceuticals' Interest Expenses' 5-year high stood at $1.7 million during Q3 2018, with a 5-year trough of -$127000.0 in Q4 2018.